A serious challenge in fighting the COVID-19 pandemic: SARS-CoV-2 vaccines in oncologic patients

In 2020, the world started to face the rapid spread of a new coronavirus, SARS-CoV-2, that causes the severe respiratory syndrome called COVID-19. COVID-19 soon developed as a pandemic that, in just over a year and a half, has dramatically affected the lives, social behaviors, and economy globally. The COVID-19 pandemic has caused over 4 million deaths around the world, especially in patients with pre-existing medical conditions that make them more vulnerable. In this regard, patients with cancer are at higher risk of being infected by SARSCoV- 2 and develop severe disease.

Read more in the FULL TEXT

Table of Content: Vol. 1 (No. 3) 2021 September

Follow us on LinkedIn
Follow us on Twitter